Canadian cannabis firm Tilray's Q1 revenue up 5%, net income $1.5 mln

Overview * Tilray fiscal Q1 2026 net revenue rises 5% yr/yr to $209.5 mln * Net income for fiscal Q1 2026 was $1.5 mln, a turnaround from a net loss * Adjusted EBITDA for fiscal Q1 2026 increased 9% to $10.2 mln Outlook * Tilray reiterates fiscal year 2026 adjusted EBITDA outlook of $62 mln to $72 mln Result Drivers * OPERATIONAL EFFICIENCIES – Co attributes net income improvement to operational efficiencies and focus on profitability * CANADIAN CANNABIS GROWTH – Canadian adult-use cannabis gross revenue increased 12%, maintaining #1 position in revenue and expanding market share * INTERNATIONAL REVENUE – International cannabis revenue grew 10% yr/yr Key Details Metric Beat/Mis Actual Consensu s s Estimate Q1 $209.50 Revenue mln Q1 EPS Q1 $3.90 Adjusted mln Net Income Q1 Net $1.51 Income mln Analyst Coverage * The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell" * Wall Street's median 12-month price target for Tilray Brands Inc is C$1.36, about 77.2% below its October 8 closing price of C$2.41 Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)